10Indexed trials
drug · Product Intelligence
Escitalopram
Pipeline Intelligence
Escitalopram: 10 indexed trials, 10 sponsors; 0 linked Orange Book patents and 11 FDA-linked events where matched.
10Sponsors
0Orange Book patent links
11FDA-linked events
Development evidence
NCT00107120Forest Laboratories · depressionPHASE3
NCT00146900Hadassah Medical Organization · ptsdNA
NCT00177671University of Pittsburgh · alzheimersPHASE4
NCT00594269Sykehuset Innlandet HF · depressionPHASE4
NCT00595699Conrad, Erich J., M.D. · epilepsyPHASE4
NCT00693849BRC Operations Pty. Ltd. · depressionPHASE4
NCT00810069Eli Lilly and Company · depressionPHASE4
NCT01477203Medical University of Vienna · depressionPHASE4
NCT01655706University Health Network, Toronto · depressionPHASE3
NCT03108846JHSPH Center for Clinical Trials · alzheimersPHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_EXCLUSIVITYLEXAPRO · NPP2026-05-12
FDA_APPROVALESCITALOPRAM · 2025-08-29
FDA_APPROVALESCITALOPRAM OXALATE · 2025-07-15
FDA_APPROVALESCITALOPRAM OXALATE · 2016-03-31
FDA_APPROVALESCITALOPRAM OXALATE · 2015-08-28
FDA_APPROVALESCITALOPRAM OXALATE · 2015-05-26
FDA_APPROVALESCITALOPRAM OXALATE · 2012-09-11
FDA_APPROVALESCITALOPRAM OXALATE · 2012-09-11
FDA_APPROVALESCITALOPRAM OXALATE · 2012-09-11
FDA_APPROVALESCITALOPRAM OXALATE · 2012-05-03
FDA_APPROVALLEXAPRO · 2002-11-27
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.